Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans

G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
G. S. J. Mannens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. A. W. Snel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Hendrickx
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Verhaeghe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Le Jeune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Bode
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. van Beijsterveldt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Lavrijsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Leempoels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Van Osselaer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Van Peer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Meuldermans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 30 no. 5 553-563
DOI 
https://doi.org/10.1124/dmd.30.5.553
PubMed 
11950787

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 29, 2001
  • Accepted January 29, 2002
  • Published online May 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. G. S. J. Mannens1,
  2. C. A. W. Snel1,
  3. J. Hendrickx1,
  4. T. Verhaeghe2,
  5. L. Le Jeune3,
  6. W. Bode1,
  7. L. van Beijsterveldt1,
  8. K. Lavrijsen1,
  9. J. Leempoels4,
  10. N. Van Osselaer4,
  11. A. Van Peer4 and
  12. W. Meuldermans1
  1. 1Department of Preclinical Pharmacokinetics (G.S.J.M., C.A.W.S., J.H., W.B., L.v.B., K.L., W.M.), 2Department of Bioanalysis (T.V.), 3Department of Analytical Development (L.L.J.), 4Department of Clinical Pharmacology and Clinical Pharmacokinetics (J.L., N.V.O., A.V.P.), Johnson & Johnson Pharmaceutical Research and Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium
  1. G. S. J. Mannens, Department of Preclinical Pharmacokinetics, Janssen Pharmaceutica, Turnhoutseweg 30, B-2340 Beerse, Belgium. E-mailgmannens{at}prdbe.jnj.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 20170268
Sep 20172788
Oct 201796912
Nov 201737420
Dec 201745916
Jan 201815324
Feb 20181249
Mar 201844315
Apr 201835913
May 2018108421
Jun 201825112
Jul 201824612
Aug 20182447
Sep 201836112
Oct 201846513
Nov 20181798
Dec 2018471912
Jan 20195012
Feb 20196324
Mar 20194821
Apr 20195130
May 20194332
Jun 20192403
Jul 20192361
Aug 20193501
Oct 20193322
Nov 20193582
Dec 20193883
Jan 20204711
Feb 20205813
Mar 20202724
May 20208673
Jun 20203110
Jul 20203102
Aug 20201101
Sep 20203721
Oct 20205242
Nov 20204834
Dec 20204411
Jan 20213943
Feb 20215334
Mar 20213742
Apr 20215973
May 20215053
Jun 20213040
Jul 20212422
Aug 20212520
Sep 20214510
Oct 202110520
Nov 202113252
Dec 202115710
Jan 20229010
Feb 20225422
Mar 20228641
Apr 20228643
May 202211222
Jun 20228310
Jul 202211011
Aug 20227911
Sep 20226162
Oct 20226613
Nov 20225345
Dec 20224014
Jan 20233331

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (5)
Drug Metabolism and Disposition
Vol. 30, Issue 5
1 May 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans

G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
Drug Metabolism and Disposition May 1, 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans

G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
Drug Metabolism and Disposition May 1, 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of payload-containing catabolites of ADCs
  • PK Interactions of Licorice with Cytochrome P450s
  • Biotransformation of Trastuzumab and Pertuzumab
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics